Ilaria Cavallari

Ilaria Cavallari

Auto-generated profile, based on publicly available information

Ilaria Cavallari

Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Rome, Italy

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2018 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
ICIlaria Cavallari
Ilaria Cavallari
CCChristopher P Cannon
Christopher P Cannon
EBEugene Braunwald
Eugene Braunwald
EGErica L Goodrich
Erica L Goodrich
KIKyungAh Im
KyungAh Im
MOMichelle L O’dOnoghue
Michelle L O’dOnoghue
The incremental prognostic value of assessing the metabolic syndrome has been disputed. Little is known regarding its prognostic value in patients after an acute coronary syndrome. The presence of metabolic syndrome (2005 International Diabetes Federation) was assessed at baseline in SOLID-TIMI 52, a trial of patients within 30 days of acute coronary syndrome (median follow-up 2.5 years). The primary endpoint was major coronary events (coronary heart disease death, myocardial infarction or urgent coronary revascularization). At baseline, 61.6% (n = 7537) of patients met the definition of metabolic syndrome, 34.7% (n = 4247) had diabetes and 29.3% had both (n = 3584). The presence of metabolic syndrome was associated with increased risk of major coronary events (adjusted hazard ratio (adjHR) 1.29, p < 0.0001) and recurrent myocardial infarction (adjHR 1.30, p < 0.0001). Of the individual components of the definition, only diabetes (adjHR 1.48, p < 0.0001) or impaired fasting glucose (adjHR 1.21, p = 0.002) and hypertension (adjHR 1.46, p < 0.0001) were associated with the risk of major coronary events. In patients without diabetes, metabolic syndrome was numerically but not significantly associated with the risk of major coronary events (adjHR 1.13, p = 0.06). Conversely, diabetes was a strong independent predictor of major coronary events in the absence of metabolic syndrome (adjHR 1.57, p < 0.0001). The presence of both diabetes and metabolic syndrome identified patients at highest risk of adverse outcomes but the incremental value of metabolic syndrome was not significant relative to diabetes alone (adjHR 1.07, p = 0.54). After acute coronary syndrome, diabetes is a strong and independent predictor of adverse outcomes. Assessment of the metabolic syndrome provides only marginal incremental value once the presence or absence of diabetes is established.

1 September 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
EMErnesto Maddaloni
Ernesto Maddaloni
ICIlaria Cavallari
Ilaria Cavallari
MPMariangela De Pascalis
Mariangela De Pascalis
HKHillary Keenan
Hillary Keenan
KPKyoungmin Park
Kyoungmin Park
PPPaolo Pozzilli
Paolo Pozzilli

1 October 2020 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
Paolo CalabròPaolo Calabrò
Paolo Calabrò
Felice GragnanoFelice Gragnano
Felice Gragnano
ACArturo Cesaro
Arturo Cesaro
FMFabio Marsico
Fabio Marsico
IPIvana Pariggiano
Ivana Pariggiano
Raffaele De CaterinaRaffaele De Caterina
Raffaele De Caterina

1 August 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
GPGiuseppe Patti
Giuseppe Patti
ICIlaria Cavallari
Ilaria Cavallari
OHOlivier Hanon
Olivier Hanon
Raffaele De CaterinaRaffaele De Caterina
Raffaele De Caterina

17 November 2021 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
ICIlaria Cavallari
Ilaria Cavallari
EMErnesto Maddaloni
Ernesto Maddaloni
ANAnnunziata Nusca
Annunziata Nusca
DTDario Tuccinardi
Dario Tuccinardi
RBRaffaella Buzzetti
Raffaella Buzzetti
FGFrancesco Grigioni
Francesco Grigioni